SYMPHONY.BOSYMPHONY.BOBSE
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank54
3Y CAGR-22.7%
5Y CAGR-36.5%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-22.7%/yr
vs -34.3%/yr prior
5Y CAGR
-36.5%/yr
Recent acceleration
Acceleration
+11.5pp
Accelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 8.30% |
| Q3 2025 | -54.44% |
| Q2 2025 | -46.62% |
| Q1 2025 | 931.39% |
| Q4 2024 | -116.89% |
| Q3 2024 | -36.44% |
| Q2 2024 | 81.77% |
| Q1 2024 | 18.78% |
| Q4 2023 | 16.34% |
| Q3 2023 | 47.67% |
| Q2 2023 | 50.22% |
| Q1 2023 | -58.89% |
| Q4 2022 | 18.01% |
| Q3 2022 | 12.11% |
| Q2 2022 | -53.43% |
| Q1 2022 | 205.41% |
| Q4 2021 | -31.48% |
| Q3 2021 | 396.55% |
| Q2 2021 | -90.31% |
| Q1 2021 | 129.67% |
| Q4 2020 | 80.18% |
| Q3 2020 | 886.36% |
| Q2 2020 | -95.89% |
| Q1 2020 | -27.11% |
| Q4 2019 | -10.27% |
| Q3 2019 | 70.42% |
| Q2 2019 | 727.59% |
| Q1 2019 | -89.04% |
| Q4 2018 | 20.50% |
| Q3 2018 | 53.50% |
| Q2 2018 | -45.32% |
| Q1 2018 | -43.88% |
| Q4 2017 | 220.27% |
| Q3 2017 | -48.13% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q1 2017 | 0.00% |
| Q4 2015 | 0.00% |
| Q3 2015 | 0.00% |
| Q2 2015 | 0.00% |